Skip to main content

Table 3 The tissue to blood ratios of boron concentrations under the continuous-infusion protocol

From: Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy

  Intestine Liver Kidney Lung Tongue Skin Muscle Brain Tumour
L-BPA (μg/g) 1.22 ± 0.13 0.90 ± 0.09 3.80 ± 1.21 1.18 ± 0.01 1.17 ± 0.167 1.02 ± 0.38 0.93 ± 0.06 0.37 ± 0.05 1.58 ± 0.20
L-FBPA (μg/g) 1.17 ± 0.04 1.18 ± 0.19 4.40 ± 1.04 1.12 ± 0.03 1.03 ± 0.152 0.92 ± 0.01 0.74 ± 0.09 0.35 ± 0.15 1.52 ± 0.42
p value 0.46 0.11 0.52 0.048 0.33 0.65 0.044 0.80 0.85